Cloning of human Type I interferon cDNAs.

Area of Science:

• Immunology
• Molecular Biology
• Biotechnology

Background:

• Initial observations in the late 1970s revealed crude interferon samples possessed anti-tumour activity.
• This finding sparked significant research efforts globally to isolate and characterize human interferon cDNAs.
• Early research focused on interferon-beta (IFN-β), interferon-alpha (IFN-α), and interferon-gamma (IFN-γ) cloning.

Purpose of the Study:

• To detail the historical background leading to the cloning of interferon genes.
• To describe the impact of interferon gene cloning on the broader field of cytokine gene discovery.
• To highlight the initial therapeutic applications and research advancements driven by recombinant interferon production.

Main Methods:

• Identification and cloning of human interferon-β cDNA by Tadatsugu Taniguchi.
• Subsequent cloning of human interferon-α and interferon-γ cDNAs by international research groups.
• Large-scale production of recombinant interferon proteins for functional studies and therapeutic use.

Main Results:

• Successful cloning of key human interferon subtypes (IFN-β, IFN-α, IFN-γ).
• Development of recombinant interferon-α for widespread clinical use, notably in treating C-type hepatitis.
• Elucidation of interferon biological functions and molecular mechanisms of their gene expression.

Conclusions:

• The cloning of interferon genes was a pivotal moment in molecular biology and immunology.
• Interferon research paved the way for advancements in cytokine gene hunting and therapeutic protein development.
• The early success of interferons underscored their therapeutic potential and spurred further investigation into the immune system.